tiprankstipranks
Advertisement
Advertisement

AU:ATX Stock Latest News

Amplia Issues New Shares Under Executive Equity Plan, Affirms Regulatory Compliance
Company AnnouncementsAmplia Issues New Shares Under Executive Equity Plan, Affirms Regulatory Compliance
12d ago
Amplia Therapeutics Adds 240,385 New Shares to ASX Listing
PremiumCompany Announcements
Amplia Therapeutics Adds 240,385 New Shares to ASX Listing
12d ago
Amplia and ANZGOG launch narmafotinib ovarian cancer trial targeting high‑need patients
PremiumCompany Announcements
Amplia and ANZGOG launch narmafotinib ovarian cancer trial targeting high‑need patients
16d ago
Amplia advances narmafotinib program with strong pancreatic cancer data and Phase 3 readiness steps
PremiumCompany Announcements
Amplia advances narmafotinib program with strong pancreatic cancer data and Phase 3 readiness steps
26d ago
Amplia Halts New Recruitment in Pancreatic Cancer Trial After Chemo Toxicities
PremiumCompany Announcements
Amplia Halts New Recruitment in Pancreatic Cancer Trial After Chemo Toxicities
2M ago
Amplia Halts AMPLICITY Recruitment, Shifts Focus to Less Toxic Pancreatic Cancer Regimens
PremiumCompany AnnouncementsAmplia Halts AMPLICITY Recruitment, Shifts Focus to Less Toxic Pancreatic Cancer Regimens
2M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
RADX
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
Amplia posts unprecedented complete responses and survival gain in pancreatic cancer trial
PremiumCompany Announcements
Amplia posts unprecedented complete responses and survival gain in pancreatic cancer trial
2M ago
Amplia requests ASX trading halt ahead of key clinical trial data
PremiumCompany Announcements
Amplia requests ASX trading halt ahead of key clinical trial data
2M ago
Amplia Therapeutics Reappoints Experienced CFO to Support Biotech Growth
PremiumCompany Announcements
Amplia Therapeutics Reappoints Experienced CFO to Support Biotech Growth
3M ago
Amplia Expands U.S. Footprint With New Sites for Pancreatic Cancer Trial
PremiumCompany Announcements
Amplia Expands U.S. Footprint With New Sites for Pancreatic Cancer Trial
3M ago
Amplia Secures Phase 3-Ready Supply with First Large-Scale Narmafotinib Manufacture
PremiumCompany AnnouncementsAmplia Secures Phase 3-Ready Supply with First Large-Scale Narmafotinib Manufacture
4M ago
Amplia Showcases Promising Pancreatic Cancer Data for Narmafotinib at ASCO GI
Premium
Company Announcements
Amplia Showcases Promising Pancreatic Cancer Data for Narmafotinib at ASCO GI
5M ago
Amplia Deepens Next & Bio Collaboration to Test Narmafotinib–kRAS Combo in Pancreatic Cancer
Premium
Company Announcements
Amplia Deepens Next & Bio Collaboration to Test Narmafotinib–kRAS Combo in Pancreatic Cancer
5M ago
Amplia Therapeutics Reports Positive ACCENT Trial Results for Pancreatic Cancer
PremiumCompany Announcements
Amplia Therapeutics Reports Positive ACCENT Trial Results for Pancreatic Cancer
5M ago
Amplia Therapeutics Reports Promising Trial Results for Pancreatic Cancer Drug
PremiumCompany Announcements
Amplia Therapeutics Reports Promising Trial Results for Pancreatic Cancer Drug
6M ago
Amplia Therapeutics Receives FDA Support for Pancreatic Cancer Trial
PremiumCompany Announcements
Amplia Therapeutics Receives FDA Support for Pancreatic Cancer Trial
6M ago
Amplia Therapeutics Issues New Equity Securities
PremiumCompany Announcements
Amplia Therapeutics Issues New Equity Securities
7M ago
Amplia Therapeutics Expands U.S. Market Presence with OTCQB Listing
PremiumCompany AnnouncementsAmplia Therapeutics Expands U.S. Market Presence with OTCQB Listing
7M ago
Amplia Therapeutics Advances Narmafotinib Trials with Promising Results
Premium
Company Announcements
Amplia Therapeutics Advances Narmafotinib Trials with Promising Results
7M ago
Amplia Therapeutics Secures $3.77 Million R&D Tax Rebate to Boost Cancer Trials
Premium
Company Announcements
Amplia Therapeutics Secures $3.77 Million R&D Tax Rebate to Boost Cancer Trials
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >